Terms: = Uterine cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Treatment
1231 results:
1. Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countries.
Fackler MJ; Pleas M; Li Y; Soni A; Xing D; Cope L; Ali S; Van Le Q; Van Nguyen C; Pham HT; Duong LM; Vanden Berg E; Wadee R; Michelow P; Chen WC; Joffe M; Fjeldbo CS; Lyng H; Sukumar S
Clin Epigenetics; 2024 Apr; 16(1):56. PubMed ID: 38643219
[TBL] [Abstract] [Full Text] [Related]
2. Predicting treatment plan approval probability for high-dose-rate brachytherapy of cervical cancer using adversarial deep learning.
Gao Y; Gonzalez Y; Nwachukwu C; Albuquerque K; Jia X
Phys Med Biol; 2024 Apr; 69(9):. PubMed ID: 38537309
[No Abstract] [Full Text] [Related]
3. Artificial Intelligence-Based Radiotherapy Contouring and Planning to Improve Global Access to cancer Care.
Court LE; Aggarwal A; Jhingran A; Naidoo K; Netherton T; Olanrewaju A; Peterson C; Parkes J; Simonds H; Trauernicht C; Zhang L; Beadle BM;
JCO Glob Oncol; 2024 Mar; 10():e2300376. PubMed ID: 38484191
[TBL] [Abstract] [Full Text] [Related]
4. Should we use risk selection tests for HPV 16 and/or 18 positive cases: Comparison of p16/Ki67 and cytology.
Mazurec K; Trzeszcz M; Mazurec M; Streb J; Halon A; Jach R
J Med Virol; 2024 Mar; 96(3):e29500. PubMed ID: 38440951
[TBL] [Abstract] [Full Text] [Related]
5. Assisted reproductive technology treatment failure and the detection of intrauterine HPV through spent embryo transfer media sample.
Bai M; Sun D; Shu J; Wei D; Yuan M; Yuan Z; Liu S; Kang M; Zhang Z; Chen X; Zheng W; Feng Y; Bao S; Zhang Z; Liao H
J Med Virol; 2024 Mar; 96(3):e29468. PubMed ID: 38415499
[TBL] [Abstract] [Full Text] [Related]
6. Cadonilimab Combined with Chemotherapy with or without Bevacizumab as First-Line treatment in Recurrent or Metastatic Cervical cancer (COMPASSION-13): A Phase 2 Study.
Lou H; Cai H; Huang X; Li G; Wang L; Liu F; Qin W; Liu T; Liu W; Wang ZM; Li B; Xia Y; Wang J
Clin Cancer Res; 2024 Apr; 30(8):1501-1508. PubMed ID: 38372727
[TBL] [Abstract] [Full Text] [Related]
7. Communicable and Non-communicable Diseases Diagnosis and treatment Service Availability at Primary Health Care Units During COVID-19 Outbreak in Ethiopia.
Gonete TZ; Asseffa NA; Gashu KD; Tilahun B; Angaw DA; Jisso M; Tamiso A; Alemayehu A; Fikre R; Abdisa B; Sime H; Yesuf EA; Umer A; Kebede M; Mohammed H; Yazie B; Gurmu KK; Endehabtu BF
Ethiop J Health Sci; 2023 Oct; 33(Spec Iss 2):95-104. PubMed ID: 38352666
[TBL] [Abstract] [Full Text] [Related]
8. Impacts of ovarian reserve on conservative treatment for endometrial cancer and atypical hyperplasia.
Wu P; Shan W; Xue Y; Wang L; Liu S; Chen X; Luo X
Front Endocrinol (Lausanne); 2023; 14():1286724. PubMed ID: 38250737
[TBL] [Abstract] [Full Text] [Related]
9. Application of transabdominal ultrasound- and laparoscopy-guided percutaneous microwave ablation for treating uterine fibroids: 24-month follow-up outcomes.
Chen T; Ren Q; Ge Q; Wang F; Jin Y; Liu P; Ma Q
Arch Gynecol Obstet; 2024 Mar; 309(3):1043-1052. PubMed ID: 38194092
[TBL] [Abstract] [Full Text] [Related]
10. Relationship between Cervicovaginal Microecological Changes and HPV16/18 Infection and Cervical cancer in Women of Childbearing Age.
Zhang Z; Yang Y; Zhang L; Wu Y; Jia P; Ma Q; Wang D
Ann Clin Lab Sci; 2023 Nov; 53(6):825-834. PubMed ID: 38182150
[TBL] [Abstract] [Full Text] [Related]
11. [Survival analysis of malignant tumors in cancer registration areas of Hubei province in China, 2013 to 2015].
Yao S; Xiong B; Tuo JY; Qin Y; Meng FD; Xia YF; Zhang M; Wei SZ
Zhonghua Zhong Liu Za Zhi; 2023 Dec; 45(12):1051-1056. PubMed ID: 38110313
[No Abstract] [Full Text] [Related]
12. Epidemiology, site-specific characteristics and survival of carcinosarcoma: a retrospective study based on SEER database.
Tang LS; Zhou YW; Wang JL; Zhang GX; Xu CH; Liu JY; Qiu M
BMJ Open; 2023 Dec; 13(12):e077974. PubMed ID: 38101828
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of the effectiveness and safety of photodynamic therapy in the treatment of precancerous diseases of the cervix (neoplasia) associated with the human papillomavirus: A systematic review.
Shanazarov N; Bariyeva G; Avdeyev A; Albayev R; Kisikova S; Zinchenko S; Galiev I
Photodiagnosis Photodyn Ther; 2024 Feb; 45():103925. PubMed ID: 38070631
[TBL] [Abstract] [Full Text] [Related]
14. Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trial.
Li K; Chen J; Hu Y; Wang YZ; Shen Y; Chen G; Peng W; Fang Z; Xia B; Chen X; Song K; Wang Y; Zou D; Wang YC; Han Y; Feng X; Yuan J; Guo S; Meng X; Feng C; Chen Y; Yang J; Fan J; Wang J; Ai J; Ma D; Sun C
Lancet Oncol; 2024 Jan; 25(1):76-85. PubMed ID: 38048802
[TBL] [Abstract] [Full Text] [Related]
15. Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial.
Oaknin A; Gladieff L; Martínez-García J; Villacampa G; Takekuma M; De Giorgi U; Lindemann K; Woelber L; Colombo N; Duska L; Leary A; Godoy-Ortiz A; Nishio S; Angelergues A; Rubio MJ; Fariñas-Madrid L; Yamaguchi S; Lorusso D; Ray-Coquard I; Manso L; Joly F; Alarcón J; Follana P; Romero I; Lebreton C; Pérez-Fidalgo JA; Yunokawa M; Dahlstrand H; D'Hondt V; Randall LM;
Lancet; 2024 Jan; 403(10421):31-43. PubMed ID: 38048793
[TBL] [Abstract] [Full Text] [Related]
16. Updated Trends in Cervical cancer Brachytherapy Utilization and Disparities in the United States From 2004 to 2020.
Colson-Fearon D; Han K; Roumeliotis MB; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2024 May; 119(1):154-162. PubMed ID: 38040060
[TBL] [Abstract] [Full Text] [Related]
17. Outcome prediction for symptomatic patients with fibroids who underwent uterine artery embolization.
Wu Q; Motaghi M; Tang H; Hazhirkarzar B; Shaghaghi M; Ghadimi M; Baghdadi A; Rezvani R; Mohseni A; Borhani A; Madani SP; Afyouni S; Zandieh G; Kamel IR
Clin Imaging; 2024 Jan; 105():110028. PubMed ID: 38039750
[TBL] [Abstract] [Full Text] [Related]
18. Diagnostic and pre-treatment intervals among patients with cervical cancer attending care at the Uganda cancer Institute: a cross-sectional study.
Lacika JL; Wabinga H; Kagaayi J; Opito R; Orach CG; Mwaka AD
BMC Womens Health; 2023 Nov; 23(1):633. PubMed ID: 38012615
[TBL] [Abstract] [Full Text] [Related]
19. Comparison of acceptability & efficacy of thermal ablation (thermocoagulation) & cryotherapy in VIA positive cervical lesions: A pilot study.
Verma ML; Sharma P; Singh U; Sachan R; Sankhwar PL
Indian J Med Res; 2023 Oct; 158(4):423-431. PubMed ID: 38006345
[TBL] [Abstract] [Full Text] [Related]
20. Oncologic outcomes of robot-assisted laparoscopy versus conventional laparoscopy for the treatment of apparent early-stage endometrioid adenocarcinoma of the uterus.
Lim YH; Dagher C; Abu-Rustum NR; Mueller JJ; Sonoda Y; Zivanovic O; Broach V; Leitao MM
Gynecol Oncol; 2023 Dec; 179():152-157. PubMed ID: 37980770
[TBL] [Abstract] [Full Text] [Related]
[Next]
